Kevin C. Gorman
2014
In 2014, Kevin C. Gorman earned a total compensation of $6M as President and Chief Executive Officer at Neurocrine Biosciences.
Compensation breakdown
| Bonus | $401,256 |
|---|---|
| Option Awards | $2,408,000 |
| Salary | $557,300 |
| Stock Awards | $2,546,700 |
| Other | $39,596 |
| Total | $5,952,852 |
Gorman received $2.5M in stock awards, accounting for 43% of the total pay in 2014.
Gorman also received $401.3K in bonus, $2.4M in option awards, $557.3K in salary and $39.6K in other compensation.
Rankings
In 2014, Kevin C. Gorman's compensation ranked 1,218th out of 13,032 executives tracked by ExecPay. In other words, Gorman earned more than 90.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,218 out of 13,032 | 91st |
Division Manufacturing | 450 out of 4,966 | 91st |
Major group Chemicals And Allied Products | 145 out of 1,686 | 91st |
Industry group Drugs | 115 out of 1,365 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 13 out of 236 | 95th |
Source: SEC filing on April 20, 2017.
Gorman's colleagues
We found three more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2014.
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019